Part of Ovarian Cancer Audit Feasibility Pilot (OCAFP) - Disease Profile
Ovarian Cancer Audit Feasibility Pilot Steering Group
First chapter of the Ovarian Cancer Audit Feasibility Pilot (OCAFP) - Disease profile in England: Incidence, mortality, stage and survival for ovary, fallopian tube and primary peritoneal carcinomas.
Summary
First chapter of the Ovarian Cancer Audit Feasibility Pilot (OCAFP) - Disease profile in England: Incidence, mortality, stage and survival for ovary, fallopian tube and primary peritoneal carcinomas.
Introduction to the group
Chair
Mr Andy Nordin, Consultant Gynaecological Oncologist, East Kent Hospitals, Clinical Advisor, National Cancer Registration and Analysis Service (NCRAS)
Target Ovarian Cancer
Annwen Jones OBE, Chief Executive
Rebecca Rennison, Director of Public Affairs and Services
British Gynaecological Cancer Society (BGCS)
Professor Sudha Sundar, President and Consultant Gynaecological Oncologist, Pan Birmingham Gynaecological Cancer Centre, Professor of Gynaecological Cancer, University of Birmingham
Mr Jo Nieto, Chair of Training Subgroup and Consultant Gynaecological Oncologist, Norfolk and Norwich University Hospitals
National Cancer Registration and Analysis Service (NCRAS)
Dr Charlie Turner, Senior Cancer Data Analyst, National Cancer Registration and Analysis Service (NCRAS)
Dr Craig Knott, Principal Health Data Analyst, Health Data Insight and National Cancer Registration and Analysis Service (NCRAS)
Lizz Paley, Partnerships Analytical Lead, National Cancer Registration and Analysis Service (NCRAS)
This work uses data that has been provided by patients and collected by the NHS as part of their care and support. The data are collated, maintained and quality assured by the National Disease Registration Service, which is part of NHS England.
Last edited: 30 March 2023 8:22 pm